National Centre for Neuroimmunology and Emerging Diseases, Griffith University, 1 Parklands Drive, Southport Gold Coast, Brisbane, QLD, 4222, Australia.
Consortium Health International for Myalgic Encephalomyelitis, Griffith University, Gold Coast, Brisbane, QLD, 4222, Australia.
Qual Life Res. 2024 Dec;33(12):3229-3243. doi: 10.1007/s11136-024-03794-x. Epub 2024 Oct 3.
Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) is associated with long-term disability and poor quality of life (QoL). Cardinal ME/CFS symptoms (including post-exertional malaise, cognitive dysfunction and sleep disturbances) have been observed in Post COVID-19 Condition (PCC). To gain further insight into the potential role of ME/CFS as a post-COVID-19 sequela, this study investigates associations between symptoms and patient-reported outcomes, as well as symptom clusters.
Participants included Australian residents aged between 18 and 65 years formally diagnosed with ME/CFS fulfilling the Canadian or International Consensus Criteria or PCC meeting the World Health Organization case definition. Validated, self-administered questionnaires collected participants' sociodemographic and illness characteristics, symptoms, QoL and functional capacity. Associations between symptoms and patient-reported outcomes were investigated with multivariate linear regression models. Hierarchical cluster analysis was performed to identify symptom clusters.
Most people with ME/CFS (pwME/CFS) and people with PCC (pwPCC) were female (n = 48/60, 80.0% and n = 19/30, 63.3%, respectively; p = 0.12). PwME/CFS were significantly younger (x̄=41.75, s = 12.91 years) than pwPCC (x̄=48.13, s =10.05 years; p =0.017). Autonomic symptoms (notably dyspnoea) were associated with poorer scores in most patient-reported outcome domains for both cohorts. None of the four symptom clusters identified were unique to ME/CFS or PCC. Clusters were largely delineated by the presence of gastrointestinal and neurosensory symptoms, illness duration, ME/CFS criteria met and total symptoms.
Illness duration may explain differences in symptom burden between pwME/CFS and pwPCC. PCC diagnostic criteria must be refined to distinguish pwPCC at risk of long-term ME/CFS-like illness and subsequently deliver necessary care and support.
肌痛性脑脊髓炎/慢性疲劳综合征(ME/CFS)与长期残疾和生活质量差(QoL)有关。在新冠后状况(PCC)中观察到 ME/CFS 的主要症状(包括活动后不适、认知功能障碍和睡眠障碍)。为了更深入地了解 ME/CFS 作为新冠后后遗症的潜在作用,本研究调查了症状与患者报告的结果之间的关联,以及症状群。
参与者包括年龄在 18 至 65 岁之间的澳大利亚居民,他们被正式诊断患有 ME/CFS,符合加拿大或国际共识标准或符合世界卫生组织病例定义的 PCC。使用经过验证的自我管理问卷收集参与者的社会人口统计学和疾病特征、症状、QoL 和功能能力。使用多元线性回归模型调查症状与患者报告结果之间的关联。进行层次聚类分析以确定症状群。
大多数 ME/CFS 患者(pwME/CFS)和 PCC 患者(pwPCC)为女性(n=48/60,80.0%和 n=19/30,63.3%;p=0.12)。pwME/CFS 明显比 pwPCC 年轻(x̄=41.75,s=12.91 岁)(x̄=48.13,s=10.05 岁;p=0.017)。自主症状(特别是呼吸困难)与两个队列的大多数患者报告结果领域的较差评分相关。确定的四个症状群都不是 ME/CFS 或 PCC 所特有的。集群主要由胃肠道和神经感觉症状、疾病持续时间、符合 ME/CFS 标准和总症状的存在来划定。
疾病持续时间可能解释了 pwME/CFS 和 pwPCC 之间症状负担的差异。必须改进 PCC 诊断标准,以区分有长期 ME/CFS 样疾病风险的 pwPCC,并随后提供必要的护理和支持。